Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Relapsed Pediatric Solid Tumor × Axitinib × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 2 Relapsed Pediatric Solid Tumor 1 Refractory or Recurrent Solid Tumors, Excluding CNS Tumors 1

Interventions

pazopanib 2 Ifosfamide 2 Etoposide 2 Carboplatin 2 vandetanib 1 ruxolitinib 1 fludarabine 1 Vemurafenib 1 Trastuzumab 1 Sorafenib 1 Imatinib Mesylate 1 Everolimus 1 Erlotinib Hydrochloride 1 Dasatinib 1 Cytarabine 1 Crizotinib 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Samsung Medical Center

Phase 2 Unknown

Other solid neoplasm

Relapsed Pediatric Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡